Cargando…
The miR-34 family and its clinical significance in ovarian cancer
The tumor suppressor miR-34 family is transcriptionally induced by p53. Clinical significance of the various miR-34 family members has not been studied in ovarian cancer. In 228 ovarian cancers and in 19 non-neoplastic fallopian tube samples we analysed miR-34 a/b/c expression in relation to clinico...
Autores principales: | Welponer, Hannah, Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Marth, Christian, Hackl, Hubert, Fiegl, Heidelinde, Zeimet, Alain G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995379/ https://www.ncbi.nlm.nih.gov/pubmed/32047551 http://dx.doi.org/10.7150/jca.33831 |
Ejemplares similares
-
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in
ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2018) -
Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2019) -
Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019) -
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2018) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020)